tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Compare Monopar Therapeutics Inc (MNPR) vs. Competitors

572 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$53.61
$388.34M
100.66%
8 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$1.56
$106.65M
-4.09
-38.82%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$7.29
$430.90M
-2.36
76.09%
4 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$5.45
$478.70M
-2.55
17.33%
7 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.32
$50.79M
-1.59
-81.88%
3 Buy
2 Hold
0 Sell
Moderate Buy
Silence Therapeutics
$5.85
$276.32M
-3.24
154.35%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
58.03
25.41
77.90%
CRDF
Cardiff Oncology
1.56
-1.05
-40.23%
VNDA
Vanda
7.29
3.16
76.51%
VSTM
Verastem
5.45
0.17
3.22%
MREO
Mereo Biopharma Group Plc
0.32
-1.58
-83.21%
SLN
Silence Therapeutics
5.85
3.67
168.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts